Evidence of metastatic spread should routinely be sought when examining patients. For patients with lesions less than 1 mm thick, close followup with biannual physical and skin examination is ...

Lung cancer was nowhere on her radar. "We're definitely seeing more and more, not only lung cancer, but really all cancers in ...

An pioneering new drug causes tiny cancer cells to glow during surgery. Ascension Saint Thomas Dr. John F. Lazar said: "It's ...

Gilead Sciences GILD announced that its first-in-class Trop-2-directed antibody-drug conjugate, Trodelvy (sacituzumab ...

A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer. Precise ...

Unloxcyt was approved by the FDA as a new treatment for patients with locally advanced or metastatic cutaneous squamous cell ...

Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung cancer. And devising ways to sense these compounds could help doctors ...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

The following is a summary of “How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

Study: Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer. Image Credit: crystal light/Shutterstock In a recent study published ...